Kyle Bass Gets More Wins As PTAB Axes Celgene Patents
An organization started by hedge fund manager Kyle Bass to challenge drug patents scored two more wins Wednesday when the Patent Trial and Appeal Board found that Celgene Corp. patents related...To view the full article, register now.
Already a subscriber? Click here to view full article